Inhibition of Ocular Inflammation by Chalcone Derivatives and Prednisolone

Journal of Ocular Pharmacology

Volumn 8, Issue 3, 1992, Pages 213-223

  Chiou, George C Y ^a,b   Yao, Quan Sheng ^a   Varma, Rajender S ^b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' HYDROXYCHALCONE; 2' HYDROXYCHALCONE HYDRAZONE; 2' HYDROXYCHALCONE PHENYL HYDRAZONE; 4,4' DIHYDROXYCHALCONE; CHALCONE DERIVATIVE; ENDOTOXIN; EYE DROPS; LENS PROTEIN; OCULAR ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISOLONE ACETATE; RVC 556; RVC 574; RVC 574P; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER DISEASE; ARTICLE; CONTROLLED STUDY; EYE INFLAMMATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RABBIT; RAT; TOPICAL DRUG ADMINISTRATION; UVEITIS;

ANIMAL; CHALCONE; CRYSTALLINS; ENDOTOXINS; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; OPHTHALMIC SOLUTIONS; PREDNISOLONE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; UVEITIS, ANTERIOR; UVEITIS, POSTERIOR;

EID: 0026453377     PISSN: 87563320     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.1992.8.213     Document Type: Article

References (13)

1. Bhattacherjee, Z., Hammon, B., Salmon, J. and Eckins, K. Effects of lipoxygenase products on leukocyte accumuuation in the rabbit eye. In Leukotrienes and Other Lipoxygenase Products, Samuelsson, B. and Paoletti, R., eds. Raven Press, New York, 1982, pp. 325–330.
2. Brown, F.J., Bernstein, P.R., Cronk, L.A., Dosset, D.L., Hebbel, K.C., Maduskuie, T.P., Shapiro, H.S., Vacek, E.P., Yee, Y.K., Willard, A.K., Krell, R.D. and Snyder, D.W. Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes. J. Med. Chem. 32:807–826, 1989.
3. Chang, M.S. and Chiou, G.C.Y. Prevention of lens protein-induced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors. J. Ocular Pharmacol. 5:353–360, 1989.
4. Chiou, G.C.Y. and Chang, M.S. Ocular infaammation induced by lens protein and its prevention with new agents. In New Trends in Lipid Mediators Research, Braquet, P. and Robinson, L.P. eds. S. Karger, Basel, Switzerland, 1990, pp. 94–109, 1990.
5. Chiou, L.Y. and Chiou, G.C.Y. Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit. J. Ocular Pharmacol. 1:383–389, 1985.
6. Dhar, D.N. The Chemistry of Chalcones and Related Compounds, John Wiley & Sons, Inc., New York, NY, 1981, p. 25.
7. Ellis, P.P. Ocular Therapeutics and Pharmacology, C.B. Mosby, St. Louis, MO., 1985, pp. 212–227.
8. Kallay, F., Janzso, G. and Koczar, I. Thermal rearrangement of 2′-hydroxychal-cone hydrazone and flavanone hydrazone derivatives. Tetrahedron 21:3037–3041, 1965 a.
9. Kallay, F., Janzso, G. and Koczar, I. The reaction of flavanone with hydrazine. Tetrahedron 21:19–24, 1965 b.
10. Marshall, W.S., Whitesitt, C.A., Goodson, T., Roman, C., Rinkema, L. and Fleisch, J.H. Structure-accivity relationships (SAR) of the 3-alkyl substituents among a series of hydroxyacetophenone leukotriene antagonists. Agents and Actions 21:275–277, 1987.
11. Miyano, K. and Chiou, G.C.Y. Pharmacological prevention of ocular infaammation induced by lens proteins. Ophthalmic Res. 16:256–263, 1984.
12. Polansky, J.R. and Weinreb, R.N. Antiinflammatory agents: Steroids as antiinfaammatory agents. In: Pharmacology of the Eye, Sears M.L. ed. Springer-Verlag, New York, NY, 1985, pp. 459–538.
13. Varma, R.S. and Chiou, G.C.Y. Chemistry and vascular dilating actions of pharmacologically active natural products from medicinal plants. Int. J. Oriental Medicine 14:63–91, 1989.